MedTrace Logo

Trial for A Novel Facilitated Antegrade Steering Technique in Revascularization of Coronary Chronic Total Occlusions

NCT03901079 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2023-12-08

Study results available
· View outcomes & findings →

Summary

To assess the safety and efficacy of the BridgePoint CTO system in recanalization of CTO lesions which are resistant to a conventional wire approach in a multicenter study in Chinese population

Conditions

Interventions

OTHER

single-arm study

single-arm study

Sponsors & Collaborators

  • Boston Scientific Corporation

    lead INDUSTRY

Principal Investigators

  • Yuejin Yang, Doc. · Chinese Academy of Medical Sciences, Fuwai Hospital

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-08
Primary Completion
2020-01-10
Completion
2021-03-24

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03901079 on ClinicalTrials.gov